2023 article

Mini-Review: Enteric glia of the tumor microenvironment: An affair of corruption

Mariant, C. L., Bacola, G., & Van Landeghem, L. (2023, September 25). NEUROSCIENCE LETTERS, Vol. 814.

By: C. Mariant n, G. Bacola n  & L. Van Landeghem n

author keywords: Enteric glial cell; Colon cancer; Tumor microenvironment; Cancer stem cell; Intestinal stem cell
UN Sustainable Development Goal Categories
16. Peace, Justice and Strong Institutions (OpenAlex)
Source: Web Of Science
Added: March 4, 2024

The tumor microenvironment corresponds to a complex mixture of bioactive products released by local and recruited cells whose normal functions have been “corrupted” by cues originating from the tumor, mostly to favor cancer growth, dissemination and resistance to therapies. While the immune and the mesenchymal cellular components of the tumor microenvironment in colon cancer have been under intense scrutiny over the last two decades, the influence of the resident neural cells of the gut on colon carcinogenesis has only very recently begun to draw attention. The vast majority of the resident neural cells of the gastrointestinal tract belong to the enteric nervous system and correspond to enteric neurons and enteric glial cells, both of which have been understudied in the context of colon cancer development and progression. In this review, we especially discuss available evidence on enteric glia impact on colon carcinogenesis. To highlight “corrupted” functioning in enteric glial cells of the tumor microenvironment and its repercussion on tumorigenesis, we first review the main regulatory effects of enteric glial cells on the intestinal epithelium in homeostatic conditions and we next present current knowledge on enteric glia influence on colon tumorigenesis. We particularly examine how enteric glial cell heterogeneity and plasticity require further appreciation to better understand the distinct regulatory interactions enteric glial cell subtypes engage with the various cell types of the tumor, and to identify novel biological targets to block enteric glia pro-carcinogenic signaling.